Recently, our group identified two cellular proliferation-associated markers predicting favorable survival for CRC patients; one is PDZ-binding kinase (PBK) (Nagano-Matsuo et al., 2021), and the other is phospho-histone H3 (PHH3) (Koshino et al., 2021). This evidence concerns the gene PBK and colorectal carcinoma.